Skip to main content
. Author manuscript; available in PMC: 2014 Jan 9.
Published in final edited form as: Kidney Int. 2013 May 15;84(3):10.1038/ki.2013.170. doi: 10.1038/ki.2013.170

Figure 2.

Figure 2

Variation in facility use of antithrombotic agents, by geographic region. N=20,475 patients from DOPPS phases 3 and 4 (2005–2010) in facilities with at least 7 patients with medication use records.